GO:0006655 phosphatidylglycerol biosynthetic process: Lipid Membrane Biogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006655 describes the enzymatic steps that build phosphatidylglycerol (PG), a major anionic phospholipid of bacterial, mitochondrial and photosynthetic membranes.
• In bacteria and photosynthetic organisms, PG synthesis starts with glycerol-3-phosphate acylation and proceeds through phosphatidic acid and CDP-diacylglycerol intermediates.
• In mitochondria, PG is the precursor of cardiolipin, a lipid required for respiratory chain organization and mitochondrial function.
• PG is a structural lipid of pulmonary surfactant and contributes to surface tension reduction in the alveolus.
• Anionic phospholipids such as PG are targeted by host defense proteins and bacterial effectors, making this pathway relevant to infection biology.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of PG biosynthetic genes in human cells and microbes.
Description
Phosphatidylglycerol (PG) is an anionic glycerophospholipid found in bacterial cytoplasmic membranes, mitochondrial inner membranes and photosynthetic membranes, and its biosynthesis is captured by the Gene Ontology term GO:0006655, phosphatidylglycerol biosynthetic process. The term covers the chemical reactions and pathways that convert simple glycerol derivatives and acyl donors into mature PG molecules, a process that is essential for membrane integrity, protein-lipid interactions and, in mitochondria, cardiolipin production. Because PG is a charged lipid, it also influences the recruitment of peripheral membrane proteins and the activity of membrane-associated enzymes. Researchers study GO:0006655 to understand how cells build and remodel anionic membranes, how mitochondrial lipid composition is maintained, and how pathogens or host defense molecules interact with PG-rich surfaces. In photosynthetic organisms, PG biosynthesis is required for thylakoid membrane function and for the assembly of photosynthetic complexes. In mammals, PG is a key component of pulmonary surfactant and a precursor to mitochondrial cardiolipin, linking this pathway to respiratory physiology and mitochondrial disease. The pathway is therefore a convergence point for microbiology, organelle biology, lung physiology and infection research.
phosphatidylglycerol biosynthetic process At A Glance
| GO ID | GO:0006655 |
|---|---|
| GO term | phosphatidylglycerol biosynthetic process |
| Ontology | biological_process |
| Synonym | phosphatidylglycerol anabolism; phosphatidylglycerol biosynthesis; phosphatidylglycerol formation; phosphatidylglycerol synthesis |
| Major function | Production of phosphatidylglycerol, an anionic phospholipid used in bacterial, mitochondrial and photosynthetic membranes |
| Pathway intermediates | Glycerol-3-phosphate, phosphatidic acid, CDP-diacylglycerol, phosphatidylglycerophosphate |
| Key enzymes | Glycerol-3-phosphate acyltransferase, phosphatidate cytidylyltransferase, phosphatidylglycerophosphate synthase, phosphatidylglycerophosphate phosphatase |
| Downstream product | Cardiolipin in mitochondria and photosynthetic membranes |
| Disease relevance | Surfactant dysfunction, mitochondrial membrane disorders, bacterial membrane targeting |
What Is GO:0006655?
GO:0006655, phosphatidylglycerol biosynthetic process, is defined by the Gene Ontology as the chemical reactions and pathways resulting in the formation of phosphatidylglycerols, a class of phospholipids in which the phosphatidyl group is esterified to the hydroxyl group of glycerol. In practical terms, it describes the enzymatic route from glycerol-3-phosphate and acyl-CoA donors through phosphatidic acid and CDP-diacylglycerol to phosphatidylglycerol, including the phosphatidylglycerophosphate intermediates that are dephosphorylated to yield the final lipid. The term is a biological process and is distinct from catabolic or remodeling terms that remove or modify PG after synthesis.
Why Is phosphatidylglycerol biosynthetic process Important in Cell Biology?
GO:0006655 is important because phosphatidylglycerol is not a minor lipid: it is a major anionic component of bacterial membranes, a structural lipid of mitochondrial inner membranes and a precursor of cardiolipin, and it is a key surfactant phospholipid in the lung. Defects in PG synthesis or availability can alter membrane charge, protein recruitment and organelle function, and the pathway is a target of antimicrobial peptides and bacterial effectors that bind anionic phospholipids. Understanding this process therefore informs mitochondrial biology, respiratory physiology, infection biology and the development of lipid-targeted therapeutics.
• PG is a major anionic phospholipid required for bacterial membrane function and is targeted by host defense molecules.
• PG is the immediate precursor of cardiolipin, a lipid essential for mitochondrial respiratory chain organization.
• PG is a component of pulmonary surfactant and contributes to alveolar surface tension regulation.
• PG biosynthesis supports thylakoid membrane assembly and photosynthetic function in plants and algae.
• Bacterial effectors can target PG and related anionic lipids, linking the pathway to host-pathogen interactions.
• Altered PG metabolism can affect membrane protein activity and organelle homeostasis.
• The pathway provides enzymes that are potential antibacterial targets because of their role in membrane biogenesis.
• PG synthesis intersects with lipid remodeling pathways that generate bis(monoacylglycero)phosphate in mammalian cells.
• Studying PG biosynthesis helps interpret lipidomic changes in mitochondrial and surfactant-related disease models.
• CRISPR-based models enable causal testing of PG biosynthetic genes in human and microbial systems.
What Happens During phosphatidylglycerol biosynthetic process?
Acylation of glycerol-3-phosphate
In simple terms: The cell first attaches fatty acids to a glycerol backbone to make a lipid intermediate.
The pathway begins with the acylation of glycerol-3-phosphate by glycerol-3-phosphate acyltransferase to form lysophosphatidic acid, which is further acylated to phosphatidic acid. This step establishes the diacylglycerol backbone that will carry the phosphatidyl group in the final PG molecule. In photosynthetic organisms, these early acyltransferases are localized to plastid and endoplasmic reticulum membranes and contribute to the acyl composition of thylakoid lipids.
Formation of CDP-diacylglycerol
In simple terms: The lipid intermediate is activated by attaching a nucleotide carrier so it can react with glycerol-3-phosphate.
Phosphatidic acid is converted to CDP-diacylglycerol by phosphatidate cytidylyltransferase (CDP-diacylglycerol synthase). CDP-diacylglycerol is a central activated intermediate used not only for PG synthesis but also for phosphatidylinositol and cardiolipin branches, making this step a regulatory node in anionic lipid metabolism. In mitochondria, CDP-diacylglycerol generated in the inner membrane is channeled toward PG and cardiolipin synthesis.
Condensation to phosphatidylglycerophosphate
In simple terms: The activated lipid is joined to glycerol-3-phosphate to form a PG precursor with an extra phosphate.
CDP-diacylglycerol condenses with glycerol-3-phosphate to form phosphatidylglycerophosphate (PGP), releasing CMP; this reaction is catalyzed by phosphatidylglycerophosphate synthase. PGP synthase is a membrane-embedded enzyme and represents the committed step specific to PG biosynthesis. In bacteria and photosynthetic organisms, this step occurs at the inner or thylakoid membrane and is essential for producing the anionic lipid pool.
Dephosphorylation to mature phosphatidylglycerol
In simple terms: A phosphate group is removed from the precursor to yield the final phosphatidylglycerol lipid.
Phosphatidylglycerophosphate phosphatase removes the terminal phosphate from PGP to produce phosphatidylglycerol. In mitochondria, this dephosphorylation is required for the subsequent conversion of PG to cardiolipin by cardiolipin synthase. In photosynthetic organisms, the mature PG is incorporated into thylakoid membranes where it contributes to the anionic lipid environment needed for photosynthetic complex function.
Trafficking and utilization of phosphatidylglycerol
In simple terms: Once made, phosphatidylglycerol is moved to the right membrane and used as a building block or signaling lipid.
Newly synthesized PG is distributed to bacterial membranes, mitochondrial inner membranes and thylakoid membranes, where it can be further converted to cardiolipin or remodeled into other lipids. In mammalian cells, PG-related lipids can enter pathways that generate bis(monoacylglycero)phosphate, an endolysosomal lipid involved in membrane dynamics. The availability of PG also influences the binding of peripheral proteins that recognize anionic phospholipids, including host defense chemokines and bacterial effectors.
Key Genes Involved in GO:0006655 phosphatidylglycerol biosynthetic process
The genes and enzymes below represent the core machinery and regulatory nodes associated with phosphatidylglycerol biosynthesis across bacteria, mitochondria and photosynthetic organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GPAT | Glycerol-3-phosphate acyltransferase; initiates acylation of glycerol-3-phosphate | Early step of PG and glycerophospholipid synthesis; target for lipid pathway studies |
| AGPAT | Acylglycerophosphate acyltransferase; converts lysophosphatidic acid to phosphatidic acid | Determines acyl composition of PG precursors |
| CDS | CDP-diacylglycerol synthase; activates phosphatidic acid | Central node for PG, PI and cardiolipin branches |
| PGS1 | Phosphatidylglycerophosphate synthase; committed PG synthesis enzyme | Key enzyme for PG production in bacteria, mitochondria and plastids |
| PTPMT1 | Phosphatidylglycerophosphate phosphatase; dephosphorylates PGP to PG | Mitochondrial PG synthesis and cardiolipin precursor supply |
| CLS1 | Cardiolipin synthase; converts PG to cardiolipin | Links PG biosynthesis to mitochondrial cardiolipin and respiratory function |
| PLD | Phospholipase D-like enzymes; remodel phospholipids | May influence PG turnover and membrane lipid remodeling |
| LPGAT | Lysophosphatidylglycerol acyltransferase; remodels PG acyl chains | Acyl chain remodeling of PG and related lipids |
| MBOAT | Membrane-bound O-acyltransferase family members; acylate lipids | Potential roles in PG and cardiolipin maturation |
| PGS1 homologs in plants | Plastid PG synthesis | Thylakoid membrane biogenesis and photosynthesis |
| PGP phosphatase homologs | Dephosphorylation of PGP | PG maturation in bacteria and organelles |
| CDP-DAG pathway enzymes | Supply activated lipid intermediates | Coordination of anionic lipid synthesis |
| Surfactant-associated lipid enzymes | Production of surfactant phospholipids including PG | Pulmonary surfactant biology and respiratory disease models |
| BMP synthesis enzymes | Generate bis(monoacylglycero)phosphate from PG-related lipids | Endolysosomal lipid biology and membrane dynamics |
| T6SS effector targets | Bacterial effectors that bind anionic lipids including PG | Host-pathogen interaction and antibacterial targeting |
| Chemokine-lipid interaction proteins | Bind anionic phospholipids such as PG | Antimicrobial host defense without resistance |
| Mitochondrial membrane organizers | Maintain inner membrane lipid environment | Mitochondrial function and disease modeling |
| Photosynthetic complex assembly factors | Require PG for thylakoid assembly | Plant and algal photosynthesis research |
How Is phosphatidylglycerol biosynthetic process Regulated?
Phosphatidylglycerol biosynthesis is regulated at the level of enzyme expression, substrate availability and membrane lipid homeostasis. In bacteria and photosynthetic organisms, the committed enzyme PGS1 and the CDP-diacylglycerol synthase step are sensitive to the balance between phosphatidic acid, CDP-diacylglycerol and downstream products, so flux is adjusted to meet membrane demand. In mitochondria, PG synthesis is coupled to cardiolipin production, and perturbations in mitochondrial lipid metabolism can alter the abundance of PG and cardiolipin. In mammalian cells, PG-related lipids intersect with endolysosomal pathways that generate bis(monoacylglycero)phosphate, indicating cross-regulation between anionic lipid pools. Host defense molecules and bacterial effectors that bind anionic phospholipids can also modulate the effective availability of PG at membranes, indirectly influencing pathway output.
phosphatidylglycerol biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PGS1 | Mitochondrial PG synthesis and cardiolipin precursor supply | Knockout and point-mutation cell lines with lipidomics |
| PTPMT1 | Mitochondrial phospholipid phosphatase; PG/cardiolipin balance | Knockout cells and rescue with wild-type or catalytically dead enzyme |
| CLS1 | Cardiolipin synthesis from PG; mitochondrial function | Knock-in of tagged CLS1 for localization and interaction studies |
| Surfactant lipid enzymes | Pulmonary surfactant composition and function | Overexpression and knockout in lung epithelial cell models |
| BMP synthesis enzymes | Endolysosomal lipid production from PG-related pools | Knockout and overexpression in mammalian cells with lipidomics |
Mitochondrial membrane disorders
PG is the precursor of cardiolipin, a mitochondrial phospholipid required for respiratory chain organization and inner membrane function. Disturbances in PG and cardiolipin synthesis can impair mitochondrial energy metabolism and are relevant to inherited mitochondrial diseases and acquired mitochondrial dysfunction. Experimental models that alter PG biosynthetic enzymes help define how lipid composition affects oxidative phosphorylation and organelle integrity.
Pulmonary surfactant dysfunction
Phosphatidylglycerol is a component of pulmonary surfactant, the lipid-protein mixture that reduces alveolar surface tension. Changes in surfactant phospholipid composition, including PG, have been studied in the context of respiratory distress and surfactant metabolism disorders. Cell and animal models of surfactant lipid synthesis provide a way to test how PG availability affects lung physiology.
Bacterial membrane targeting and infection
Anionic phospholipids such as PG are targets of host defense chemokines that kill bacteria without triggering antimicrobial resistance, and of bacterial type VI secretion system effectors with lipid-targeting activities. This makes PG biosynthesis and PG availability relevant to infection biology and to the development of new antibacterial strategies. Bacterial models with altered PG synthesis can be used to test susceptibility to these lipid-binding molecules.
Endolysosomal lipid biology
PG-related lipid pools intersect with pathways that produce bis(monoacylglycero)phosphate, a lipid enriched in endolysosomal membranes. Functionally overlapping intra- and extralysosomal pathways contribute to bis(monoacylglycero)phosphate synthesis in mammalian cells, linking PG metabolism to lysosomal membrane biology. This connection is relevant to lysosomal storage disorders and membrane trafficking research.
From phosphatidylglycerol biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for PG synthesis? | CRISPR knockout cell line with lipidomic readout |
| Does a specific catalytic residue control PG enzyme activity? | Point-mutation knock-in of the enzyme active site |
| Where does the PG biosynthetic enzyme localize? | Tagged knock-in with fluorescent or affinity tag |
| Does increased PG synthesis alter membrane properties? | Overexpression of PG biosynthetic enzymes |
| Which genes modify sensitivity to PG-binding antimicrobials? | CRISPR library screening in bacterial or mammalian cells |
| How does PG availability affect mitochondrial function? | Knockout of mitochondrial PG enzymes with respirometry and lipidomics |
How to Study the phosphatidylglycerol biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | Abundance and acyl composition of PG and related lipids | Validation of knockout or overexpression phenotypes |
| Isotope tracing | Flux through PG biosynthetic intermediates | Pathway activity and substrate preference |
| Enzyme activity assay | Catalytic activity of PG biosynthetic enzymes | Functional testing of point mutations |
| Fluorescence microscopy | Subcellular localization and membrane distribution of PG | Organelle-specific synthesis studies |
| CRISPR knockout screen | Genes required for PG levels or drug sensitivity | Discovery of pathway modifiers |
| CRISPR activation screen | Genes whose upregulation changes PG biology | Identification of rate-limiting steps |
| Respirometry | Mitochondrial respiratory function | Linking PG/cardiolipin synthesis to energy metabolism |
| Surfactant lipid analysis | Phospholipid composition in surfactant models | Pulmonary surfactant research |
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics is the primary method to quantify phosphatidylglycerol and related lipids after genetic perturbation. It can resolve acyl chain composition and distinguish PG from cardiolipin and other anionic lipids, making it essential for validating GO:0006655 phenotypes. Stable isotope labeling can be used to trace flux through the pathway.
Enzymatic assays for PG biosynthetic enzymes
In vitro assays using radiolabeled or fluorescent substrates measure the activity of glycerol-3-phosphate acyltransferases, CDP-diacylglycerol synthase, PGP synthase and PGP phosphatase. These assays help determine whether a mutation affects catalysis, substrate binding or membrane insertion. Coupling enzymatic assays with lipidomics provides a direct link between enzyme function and pathway output.
Fluorescence imaging and membrane probes
Fluorescent lipid probes and tagged enzymes can visualize where PG synthesis occurs and how PG distributes within membranes. Imaging is particularly useful in mitochondria and photosynthetic membranes, where PG is enriched in specific subdomains. Co-localization with organelle markers helps assign the pathway to the correct membrane compartment.
Genetic screens and CRISPR libraries
CRISPR knockout and activation libraries can identify genes that modify PG levels or sensitivity to PG-binding molecules. Screens in bacteria and mammalian cells can uncover redundant pathways and host factors that interact with anionic lipids. Hit validation typically combines lipidomics, imaging and targeted gene editing.
How CRISPR Can Be Used to Study GO:0006655 phosphatidylglycerol biosynthetic process
Knockout
CRISPR knockout of PG biosynthetic genes such as PGS1 or PTPMT1 can abolish or reduce phosphatidylglycerol production, providing a clean loss-of-function model to test pathway requirement. Knockout cells can be profiled by lipidomics, imaging and respirometry to connect GO:0006655 to membrane and organelle phenotypes. In bacteria, knockout of PG synthesis genes can reveal essentiality and susceptibility to lipid-binding antimicrobials.
Point Mutation
Point-mutation knock-in allows precise testing of catalytic residues, substrate-binding sites or regulatory phosphorylation sites in PG biosynthetic enzymes. By comparing wild-type and mutant enzymes in an otherwise isogenic background, researchers can separate catalytic activity from scaffolding or localization functions. This approach is especially useful for enzymes with multiple domains or membrane-interacting regions.
Knock-in
Tagged knock-in of PG biosynthetic enzymes with fluorescent or affinity tags enables localization, interaction and proximity labeling studies. Knock-in of disease-associated variants can model how specific mutations affect PG synthesis and downstream cardiolipin production. Knock-in models also allow endogenous-level expression, avoiding artifacts from strong overexpression.
Overexpression
Overexpression of PG biosynthetic enzymes can increase pathway flux and reveal rate-limiting steps or membrane saturation effects. It is useful for producing sufficient material for structural and biochemical studies of PG enzymes. In mammalian cells, overexpression can test whether increased PG synthesis alters mitochondrial or endolysosomal lipid pools.
How EDITGENE Supports phosphatidylglycerol biosynthetic process Research
Researchers studying phosphatidylglycerol biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in lipid production, membrane organization or disease-relevant phenotypes. EDITGENE provides CRISPR-based cell models and screening services that allow precise, isogenic testing of PG pathway genes in human and microbial systems.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylglycerol biosynthetic process research.
Frequently Asked Questions About phosphatidylglycerol biosynthetic process
What is phosphatidylglycerol biosynthetic process?
It is the biological process defined by GO:0006655 that produces phosphatidylglycerol, an anionic phospholipid, through enzymatic steps starting from glycerol-3-phosphate and acyl donors.
What genes are involved in phosphatidylglycerol biosynthetic process?
Key genes include glycerol-3-phosphate acyltransferases, CDP-diacylglycerol synthase, PGS1 (phosphatidylglycerophosphate synthase) and PTPMT1 (phosphatidylglycerophosphate phosphatase).
Where does phosphatidylglycerol biosynthesis occur in cells?
It occurs in bacterial membranes, mitochondrial inner membranes and photosynthetic thylakoid membranes, depending on the organism.
Why is phosphatidylglycerol important for mitochondria?
Phosphatidylglycerol is the precursor of cardiolipin, a lipid required for respiratory chain organization and mitochondrial inner membrane function.
Is phosphatidylglycerol found in pulmonary surfactant?
Yes, phosphatidylglycerol is a component of pulmonary surfactant and contributes to alveolar surface tension regulation.
How is phosphatidylglycerol synthesized in bacteria?
Bacteria synthesize PG via CDP-diacylglycerol and phosphatidylglycerophosphate intermediates using dedicated synthases and phosphatases.
What is the role of PGS1 in phosphatidylglycerol synthesis?
PGS1 catalyzes the committed step, condensing CDP-diacylglycerol with glycerol-3-phosphate to form phosphatidylglycerophosphate.
Can phosphatidylglycerol biosynthesis be studied with CRISPR?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of PG biosynthetic genes and their phenotypes.
How do researchers measure phosphatidylglycerol levels?
Mass spectrometry-based lipidomics is commonly used to quantify PG and related lipids after genetic or pharmacological perturbation.
What diseases are linked to phosphatidylglycerol metabolism?
PG metabolism is linked to mitochondrial membrane disorders, pulmonary surfactant dysfunction and bacterial membrane targeting by host defense molecules.
Conclusion
GO:0006655, phosphatidylglycerol biosynthetic process, describes a conserved lipid pathway that builds an anionic phospholipid essential for bacterial membranes, mitochondrial cardiolipin production and photosynthetic membrane function. Its products influence surfactant biology, organelle function and host-pathogen interactions, making the pathway relevant to respiratory, mitochondrial and infection research. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with lipidomics and imaging, provide a rigorous framework for dissecting how PG biosynthesis is controlled and how it contributes to disease.
References
- 1. Bulfon D et al.. 2024. Functionally overlapping intra- and extralysosomal pathways promote bis(monoacylglycero)phosphate synthesis in mammalian cells.. Nat Commun 15(1):9937 PMID: 39548099
- 3. Agassandian M et al.. 2013. Surfactant phospholipid metabolism.. Biochim Biophys Acta 1831(3):612-25 PMID: 23026158
- 4. Kobayashi K et al.. 2024. Biosynthesis of phosphatidylglycerol in photosynthetic organisms.. Prog Lipid Res 93:101266 PMID: 38040200
- 5. Nicastro GG et al.. 2026. Systematic identification of Salmonella T6SS effectors uncovers diverse new families and lipid-targeting activities.. PLoS Biol 24(3):e3003680 PMID: 41843574
- 6. Mayr JA. 2015. Lipid metabolism in mitochondrial membranes.. J Inherit Metab Dis 38(1):137-44 PMID: 25082432
- 7. Batenburg JJ. 1992. Surfactant phospholipids: synthesis and storage.. Am J Physiol 262(4 Pt 1):L367-85 PMID: 1566854
- 8. Pontejo SM et al.. 2025. Chemokines kill bacteria without triggering antimicrobial resistance by binding anionic phospholipids.. Sci Adv 11(23):eads2675 PMID: 40479071
